Cargando…

A Phase 4, multicentre, randomized, single-blind clinical trial to evaluate the immunogenicity of the live, attenuated, oral rotavirus vaccine (116E), ROTAVAC®, administered simultaneously with or without the buffering agent in healthy infants in India

Background: The World Health Organization recommends that rotavirus vaccines should be included in all national immunization programs. Some currently licensed oral rotavirus vaccines contain a buffering agent (either as part of a ready-to-use liquid formulation or added during reconstitution) to red...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ella, Raches, Bobba, Radhika, Muralidhar, Sanjay, Babji, Sudhir, Vadrevu, Krishna Mohan, Bhan, Maharaj Kishan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2018
Materias:	Research Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067888/ https://www.ncbi.nlm.nih.gov/pubmed/29543547 http://dx.doi.org/10.1080/21645515.2018.1450709

Ejemplares similares

Immunogenicity and safety of two monovalent rotavirus vaccines, ROTAVAC® and ROTAVAC 5D® in Zambian infants
por: Chilengi, R., et al.
Publicado: (2021)

Safety and immunogenicity of the Rotavac and Rotasiil rotavirus vaccines administered in an interchangeable dosing schedule among healthy Indian infants: a multicentre, open-label, randomised, controlled, phase 4, non-inferiority trial
por: Kanungo, Suman, et al.
Publicado: (2022)

Diarrheal Etiology and Impact of Coinfections on Rotavirus Vaccine Efficacy Estimates in a Clinical Trial of a Monovalent Human–Bovine (116E) Oral Rotavirus Vaccine, Rotavac, India
por: Praharaj, Ira, et al.
Publicado: (2019)

ROTAVAC(®) does not interfere with the immune response to childhood vaccines in Indian infants: A randomized placebo controlled trial
por: Chandola, Temsunaro Rongsen, et al.
Publicado: (2017)

Introduction of rotavirus vaccination in Palestine: An evaluation of the costs, impact, and cost-effectiveness of ROTARIX and ROTAVAC
por: Debellut, Frédéric, et al.
Publicado: (2020)

Preclinical evaluation of safety and immunogenicity of a primary series intranasal COVID-19 vaccine candidate (BBV154) and humoral immunogenicity evaluation of a heterologous prime-boost strategy with COVAXIN (BBV152)
por: Sunagar, Raju, et al.
Publicado: (2022)

Introducing ROTAVAC® to the occupied Palestinian Territories: Impact on diarrhea incidence, rotavirus prevalence and genotype composition
por: Rennert, Wolfgang, et al.
Publicado: (2023)

Risk of intussusception after monovalent rotavirus vaccine (Rotavac) in Indian infants: A self-controlled case series analysis
Publicado: (2021)

Safety monitoring of ROTAVAC vaccine and etiological investigation of intussusception in India: study protocol
por: Reddy, Samarasimha, et al.
Publicado: (2018)

Systematic literature review on the safety and immunogenicity of rotavirus vaccines when co-administered with meningococcal vaccines
por: Pereira, Priya, et al.
Publicado: (2020)

Persistence of Immune Responses With an Inactivated Japanese Encephalitis Single-Dose Vaccine, JENVAC and Interchangeability With a Live-Attenuated Vaccine
por: Vadrevu, Krishna Mohan, et al.
Publicado: (2019)

A multi-centre, post-marketing surveillance study of Vi polysaccharide–tetanus toxoid conjugate vaccine (Typbar TCV®) in India
por: Reddy, Raghu, et al.
Publicado: (2021)

Approach to molecular characterization of partially and completely untyped samples in an Indian rotavirus surveillance program()
por: Babji, Sudhir, et al.
Publicado: (2014)

Immunogenicity of an oral rotavirus vaccine administered with prenatal nutritional support in Niger: A cluster randomized clinical trial
por: Isanaka, Sheila, et al.
Publicado: (2021)

Immunogenicity and reactogenicity of an inactivated SARS-CoV-2 vaccine (BBV152) in children aged 2–18 years: interim data from an open-label, non-randomised, age de-escalation phase 2/3 study
por: Vadrevu, Krishna Mohan, et al.
Publicado: (2022)

Comparative analysis of the immunogenicity of monovalent and multivalent rotavirus immunogens
por: Mi, Kai, et al.
Publicado: (2017)

Impact of maternal antibodies and infant gut microbiota on the immunogenicity of rotavirus vaccines in African, Indian and European infants: protocol for a prospective cohort study
por: Sindhu, Kuladaipalayam Natarajan C, et al.
Publicado: (2017)

Correction: Immunogenicity of an oral rotavirus vaccine administered with prenatal nutritional support in Niger: A cluster randomized clinical trial
por: Isanaka, Sheila, et al.
Publicado: (2021)

Immunogenicity of four doses of oral poliovirus vaccine when co-administered with the human neonatal rotavirus vaccine (RV3-BB)
por: Cowley, Daniel, et al.
Publicado: (2019)

Impact of maternal antibodies and microbiota development on the immunogenicity of oral rotavirus vaccine in African, Indian, and European infants
por: Parker, Edward P. K., et al.
Publicado: (2021)

Immunogenicity and reactogenicity of the human rotavirus vaccine, RIX4414 oral suspension, when co-administered with routine childhood vaccines in Chinese infants
por: Li, Rong-cheng, et al.
Publicado: (2015)

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial
por: Ella, Raches, et al.
Publicado: (2021)

First study conducted in Northern India that identifies group C rotavirus as the etiological agent of severe diarrhea in children in Delhi
por: Tiku, Vasundhara Razdan, et al.
Publicado: (2017)

Overstated conclusions of a non-inferiority trial testing immunogenicity and safety of homologous and heterologous booster vaccination
por: Vadrevu, Krishna Mohan
Publicado: (2023)

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial
por: Ella, Raches, et al.
Publicado: (2021)

Association of Maternal Immunity with Rotavirus Vaccine Immunogenicity in Zambian Infants
por: Chilengi, Roma, et al.
Publicado: (2016)

Predictors of oral rotavirus vaccine immunogenicity in rural Zimbabwean infants
por: Church, James A., et al.
Publicado: (2020)

The fecal microbiome and rotavirus vaccine immunogenicity in rural Zimbabwean infants
por: Robertson, Ruairi C., et al.
Publicado: (2021)

Efficacy, safety and immunogenicity of hexavalent rotavirus vaccine in Chinese infants
por: Wu, Zhiwei, et al.
Publicado: (2022)

Immunogenicity of inactivated rotavirus in rhesus monkey, and assessment of immunologic mechanisms
por: Zhou, Yan, et al.
Publicado: (2023)

Immunogenicity and protective efficacy of BBV152, whole virion inactivated SARS- CoV-2 vaccine candidates in the Syrian hamster model
por: Mohandas, Sreelekshmy, et al.
Publicado: (2021)

Ovine rotavirus strain LLR-85-based bovine rotavirus candidate vaccines: Construction, characterization and immunogenicity evaluation
por: Chang, Ji-Tao, et al.
Publicado: (2010)

Immunogenicity of rotavirus vaccine (Rotarix(TM)) in infants with environmental enteric dysfunction
por: Mwape, Innocent, et al.
Publicado: (2017)

Genotyping Rotavirus RNA from Archived Rotavirus-Positive Rapid Test Strips
por: Shulman, Lester M., et al.
Publicado: (2011)

Rotavirus gastroenteritis in Indian children < 5 years hospitalized for diarrhoea, 2012 to 2016
por: Giri, Sidhartha, et al.
Publicado: (2019)

Persistence of G10P[11] neonatal rotavirus infections in southern India
por: Babji, Sudhir, et al.
Publicado: (2021)

Impact on inequities in health indicators: Effect of implementing the integrated management of neonatal and childhood illness programme in Haryana, India
por: Taneja, Sunita, et al.
Publicado: (2015)

Immunogenicity and safety of the diphtheria, pertussis, tetanus and inactivated poliovirus vaccine when co-administered with the human rotavirus vaccine (Rotarix) in healthy Japanese infants: a phase IV randomized study
por: Gillard, Paul, et al.
Publicado: (2019)

Antigenicity and Immunogenicity of Rotavirus VP6 Protein Expressed on the Surface of Lactococcus lactis
por: Esteban, L. E., et al.
Publicado: (2013)

Balancing safety, efficacy and cost: Improving rotavirus vaccine adoption in low- and middle-income countries
por: Bhan, Anant, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_u5ijccm23b0a3lpinl9se71b3i